113 related articles for article (PubMed ID: 2099733)
1. Immunohistochemical localization of CA130 in fetal tissues, and in normal and neoplastic tissues of the female genital tract.
Nanbu Y; Fujii S; Konishi I; Nonogaki H; Sagawa N; Kobayashi F; Mori T; Saga T; Endo K
Asia Oceania J Obstet Gynaecol; 1990 Dec; 16(4):379-87. PubMed ID: 2099733
[TBL] [Abstract][Full Text] [Related]
2. Characterization of CA125 glycoprotein using 3 monoclonal antibodies with different specificities.
Kobayashi F; Sagawa N; Fujii S; Mori T; Endo K
Gynecol Obstet Invest; 1994; 37(3):199-203. PubMed ID: 8005553
[TBL] [Abstract][Full Text] [Related]
3. Tissue distribution of a coelomic-epithelium-related antigen recognized by the monoclonal antibody OC125.
Kabawat SE; Bast RC; Bhan AK; Welch WR; Knapp RC; Colvin RB
Int J Gynecol Pathol; 1983; 2(3):275-85. PubMed ID: 6196309
[TBL] [Abstract][Full Text] [Related]
4. Characterisation and clinical usefulness of CA130 antigen recognised by monoclonal antibodies, 130-22 and 145-9, in ovarian cancers.
Kobayashi H; Ohi H; Fujii T; Terao T
Br J Cancer; 1993 Feb; 67(2):237-43. PubMed ID: 7679280
[TBL] [Abstract][Full Text] [Related]
5. [Levels of CA130 in maternal sera and amniotic fluid at various gestational ages].
Kobayashi F; Sagawa N; Okagaki A; Nakamura K; Nonogaki M; Nanbu Y; Ban C; Fujii S; Mori T; Saga T
Nihon Sanka Fujinka Gakkai Zasshi; 1990 Apr; 42(4):327-32. PubMed ID: 2193069
[TBL] [Abstract][Full Text] [Related]
6. [A fundamental and clinical investigation of cancer antigen 130 (CA 130) in the field of obstetrics and gynecology].
Inaba N; Okajima Y; Ota Y; Fukazawa I; Yamaguchi T; Sato N; Sudo H; Milanga M; Takamizawa H; Fujii S
Nihon Gan Chiryo Gakkai Shi; 1989 Oct; 24(10):2426-35. PubMed ID: 2614181
[TBL] [Abstract][Full Text] [Related]
7. [Clinical evaluation of serum CA130 in patients with lung cancer].
Matsubara Y; Shiota T; Ishida H; Hanawa T; Yagi K; Kosaba S; Hatakenaka R; Funatsu T; Ikeda S
Nihon Gan Chiryo Gakkai Shi; 1989 Aug; 24(8):1557-65. PubMed ID: 2572655
[TBL] [Abstract][Full Text] [Related]
8. Occurrence of the mucinous differentiation antigen CA125 in genital tract and conductive airway epithelia of diverse mammalian species (rabbit, dog, monkey).
Nouwen EJ; Dauwe S; De Broe ME
Differentiation; 1990 Dec; 45(3):192-8. PubMed ID: 2090521
[TBL] [Abstract][Full Text] [Related]
9. [Clinical significance of serum CA130 level in women with spontaneous abortion, hydatidiform mole and early normal and tubal pregnancy].
Kobayashi F; Park KR; Yamashita M; Nonogaki M; Hoshino T; Shimada H; Ono Y; Ikeuchi M; Takashima E; Sagawa N
Nihon Sanka Fujinka Gakkai Zasshi; 1992 Nov; 44(11):1427-30. PubMed ID: 1460362
[TBL] [Abstract][Full Text] [Related]
10. Dissociation in serum CA125 concentrations measured by different monoclonal antibodies.
Sakahara H; Kousaka T; Hattori N; Tomida K; Yao Z; Hosono M; Kobayashi H; Shirato M; Endo K; Konishi J
Gynecol Oncol; 1994 Mar; 52(3):301-5. PubMed ID: 7512519
[TBL] [Abstract][Full Text] [Related]
11. Similarity and co-expression of tumour-associated antigens recognised by different monoclonal antibodies.
Sakahara H; Saga T; Endo K; Kousaka T; Hosono M; Kobayashi H; Shirato M; Konishi J
Br J Cancer; 1993 Nov; 68(5):920-5. PubMed ID: 8217607
[TBL] [Abstract][Full Text] [Related]
12. CA 125 in the epithelium closely related to the embryonic ectoderm: the periderm and the amnion.
Nanbu Y; Fujii S; Konishi I; Nonogaki H; Mori T
Am J Obstet Gynecol; 1989 Aug; 161(2):462-7. PubMed ID: 2669495
[TBL] [Abstract][Full Text] [Related]
13. Expression of a local immune defense system in the female genital tract. An immunohistochemical study.
Kondi-Paphitis A; Carvounis H; Kairi E; Frangou M; Papayanopoulou A; Deligeorgi H
Eur J Gynaecol Oncol; 1999; 20(2):141-3. PubMed ID: 10376434
[TBL] [Abstract][Full Text] [Related]
14. Spectral differences between epitopes in the cronomes of salivary CA130 and CA125.
Portela A; Cornélissen G; Halberg F; Bast RC; Fujii S; Xu F; Yu Y; Takagi M; Halberg J; Halberg F
In Vivo; 1995; 9(4):341-6. PubMed ID: 8555433
[TBL] [Abstract][Full Text] [Related]
15. An antibody-tumor model for the targeting of CA125-producing gynecologic malignancies.
Saga T; Ishiwata I; Endo K; Sakahara H; Koizumi M; Watanabe Y; Nakai T; Hosono M; Ishikawa H; Sawada M
Jpn J Cancer Res; 1990 Nov; 81(11):1141-8. PubMed ID: 2125039
[TBL] [Abstract][Full Text] [Related]
16. An investigation of NCRC11 immunoreactivity in normal and neoplastic epithelia of the female genital tract and ovary.
Hitchcock A; Ellis IO; Bell J; Robins A
Histopathology; 1989 Aug; 15(2):187-94. PubMed ID: 2777219
[TBL] [Abstract][Full Text] [Related]
17. Three novel mouse monoclonal antibodies, OM-A, OM-B, and OM-C, reactive with mucinous type ovarian tumors.
Sakakibara K; Ueda R; Ohta M; Nakashima N; Tomoda Y; Takahashi T
Cancer Res; 1988 Aug; 48(16):4639-45. PubMed ID: 2456145
[TBL] [Abstract][Full Text] [Related]
18. Recognition of ovarian cancer antigen CA125 by murine monoclonal antibody produced by immunization of lung cancer cells.
Matsuoka Y; Nakashima T; Endo K; Yoshida T; Kunimatsu M; Sakahara H; Koizumi M; Nakagawa T; Yamaguchi N; Torizuka K
Cancer Res; 1987 Dec; 47(23):6335-40. PubMed ID: 3315184
[TBL] [Abstract][Full Text] [Related]
19. CA 125 in normal tissues and carcinomas of the uterine cervix, endometrium and fallopian tube. I. Immunohistochemical detection.
Scharl A; Crombach G; Vierbuchen M; Müsch H; Bolte A
Arch Gynecol Obstet; 1989; 244(2):103-12. PubMed ID: 2712596
[TBL] [Abstract][Full Text] [Related]
20. [Basic study of CA125 measurement using a newly developed "SD-8729" IRMA kit].
Yamaguchi A; Kobayashi M; Imai T; Otake H; Matsubara K; Hatori N; Tomiyoshi K; Inoue T; Endo K
Kaku Igaku; 1993 Oct; 30(10):1245-52. PubMed ID: 8264116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
